Tag - Lupus

Feature

Lupus Foundation puzzled by negative reaction to Aurinia data

By Len Zehr As president and CEO of The Lupus Foundation of America (LFA), a role she has held for 15 years, Sandra Raymond is an outspoken advocate for the plight of lupus patients. She has worked with the board of...

September 6, 2016

Feature

XTL hopes to begin major lupus trial next year

By Len Zehr XTL Biopharmaceuticals (NASDAQ:XTLB; TASE:XTL) is aiming to begin a Phase 2b clinical trial in the first half of 2015 with its hCDR1 peptide to treat patients with systemic lupus erythematosus (SLE). “We are...

July 22, 2014

Feature

Aurinia to begin lupus nephritis trial at end of April

By Len Zehr Fresh from a US$52-million private placement, Aurinia Pharmaceuticals (TSX-V:AUP) hopes to treat its first lupus patient at the end of April in a Phase 2b clinical trial with its voclosporin...

April 15, 2014

Feature

Aurinia readies Phase 2b trial in lupus nephritis

By Len Zehr Aurinia Pharmaceuticals (TSX-V:AUP) is preparing to begin a Phase 2b clinical trial in the first quarter of 2014 with its voclosporin immunosuppressant in combination with CellCept, the standard of care for...

November 19, 2013

Tag - Lupus

Lupus Foundation puzzled by negative reaction to Aurinia data

XTL hopes to begin major lupus trial next year

Aurinia to begin lupus nephritis trial at end of April

Aurinia readies Phase 2b trial in lupus nephritis

General

More